Todd Foley, Director at Repare Therapeutics Inc. (RPTX), sold 60,924 shares at $33.90 ($1.3M) on 2021-05-18, disclosed to the SEC on 2021-05-20.
Open-market sale of $1.3M RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 21,834 | $0 | 0.0% |
| 2 | $33.90 | 6,509 | $221K | 16.4% |
| 3 | $33.90 | 6,509 | $221K | 16.4% |
| 4 | $34.61 | 3,763 | $130K | 9.7% |
| 5 | $34.61 | 3,763 | $130K | 9.7% |
| 6 | $35.14 | 40 |
| $1K |
| 0.1% |
| 7 | $34.23 | 4,029 | $138K | 10.3% |
| 8 | $34.23 | 4,029 | $138K | 10.3% |
| 9 | $35.00 | 1,939 | $68K | 5.1% |
| 10 | $34.66 | 4,122 | $143K | 10.6% |
| 11 | $34.66 | 4,122 | $143K | 10.6% |
| 12 | $35.19 | 265 | $9K | 0.7% |
| Total | $22.03 avg | 60,924 | $1.3M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |